A detailed history of Farrell Financial LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Farrell Financial LLC holds 765 shares of VRTX stock, worth $361,692. This represents 0.28% of its overall portfolio holdings.

Number of Shares
765
Previous 765 -0.0%
Holding current value
$361,692
Previous $320 Million 12.13%
% of portfolio
0.28%
Previous 0.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jul 24, 2024

BUY
$343.0 - $410.68 $262,395 - $314,170
765 New
765 $270 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Farrell Financial LLC Portfolio

Follow Farrell Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farrell Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farrell Financial LLC with notifications on news.